top of page
e. info@slimtransformation.co.uk
t. 0330 633 0138
Kickstart a Healthier Lifestyle With Our Weight Loss Plan
Next Day Delivery Available (see T&Cs, UK based only) | Meal Plans, needles, swabs & more included | Collect points to save money | Unlimited aftercare | Progress tracking tools |
Semaglutide as a promising anti-obesity drug
​
Semaglutide is a GLP-1 RA (Glucagon-Like Peptide-1 Receptor Agonist) which is administered subcutaneously once per week. It is produced by the same manufacturer as Liraglutide (Novo Nordisk).
During a Phase II dose-finding trial, the weight loss efficacy of Semaglutide appeared to be superior compared to Liraglutide & the placebo doses for those who were obese but without Type 2 Diabetes.
​
Read the full article below.
bottom of page